Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-10

Clinical Trial Update: A Clinical Trial of the Safety and Efficacy of TJ0113 Capsules in the Treatment of Patients With Age-related Hearing Loss [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of TJ0113 capsules for age-related hearing loss; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TJ0113 capsules

Snippet

Sponsor: Yilai Shu | Conditions: Age Related Hearing Loss, Deafness | NA | Status: NOT_YET_RECRUITING